Status:
RECRUITING
Acoustic Analysis of VA Sounds
Lead Sponsor:
Mario Negri Institute for Pharmacological Research
Conditions:
End Stage Renal Disease
Hemodialysis Access Failure
Eligibility:
All Genders
18-90 years
Brief Summary
End-stage renal disease (ESRD) is a growing global health problem, strictly connected with progressive ageing population and longer survival of patients living on renal replacement therapy. The majori...
Eligibility Criteria
Inclusion Criteria:
- Provision of informed consent prior to any study specific procedures.
- Patients in HD treatment that need a new VA or patients that entered the pre-dialysis program because of ESRD. In all these cases the treatment of first choice should be the creation of a distal autogenous AVF, the creation of an AVG or the proximalization of an occluded VA.
Exclusion Criteria:
- Contraindications for the creation of an autogenous AVF, for the AVG creation or the proximalization of a failed VA.
- Patients who use catheter to perform HD.
- Patients undergoing peritoneal dialysis.
- Patients with life expectancy less than 2 years.
Key Trial Info
Start Date :
May 9 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT05612022
Start Date
May 9 2023
End Date
December 1 2026
Last Update
November 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ASST HPG23 Unità di Nefrologia e Dialisi
Bergamo, BG, Italy, 24127